These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6163222)

  • 21. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
    Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B
    Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
    Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
    Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic inhibition by antithrombin III and heparin-like compounds of thrombin-induced platelet aggregation [proceedings].
    Kindness G; Williamson FB; Long WF
    Biochem Soc Trans; 1980 Feb; 8(1):85-6. PubMed ID: 6154614
    [No Abstract]   [Full Text] [Related]  

  • 24. [Characteristics of the action of an acidic sulfated polysaccharide on global blood coagulation in vitro. Preliminary study in various species of mammals and in man].
    Caporiccio B; Braun M; Vignaud M; Chalet M; Teste J; Codomier L; Catayée G
    C R Seances Soc Biol Fil; 1983; 177(4):412-20. PubMed ID: 6202380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
    Scully MF; Kakkar VV
    Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of potentiation of antithrombin III [AT-III] inhibition by sulfated xylans.
    Campbell A; Nesheim ME; Doctor VM
    Thromb Res; 1987 Aug; 47(3):341-52. PubMed ID: 2442830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prenatal pharmacology of low molecular weight heparin and pentosan polysulfate].
    Rainaut M; Forestier F; Daffos F; Fisher AM; Aiach M
    J Mal Vasc; 1987; 12 Suppl B():119-22. PubMed ID: 2452225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerance and biological activity of pentosan polysulfate after intramuscular or subcutaneous administration for ten days in human volunteers.
    Sié P; Albarede JL; Robert M; Bouloux C; Lansen J; Chigot C; Correll S; Thouvenot JP; Boneu B
    Thromb Haemost; 1986 Feb; 55(1):86-9. PubMed ID: 2422778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pentosan polysulphate administration in man on the formation of covalent complexes between heparin cofactor II and thrombin generated in plasma by contact activation.
    Dol F; Sié P; Dupouy D; Boneu B
    Thromb Haemost; 1986 Dec; 56(3):295-8. PubMed ID: 2436330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical experience with heparinoid sodium pentosan polysulfate (SP54) in the treatment of cerebral ischemia].
    Szirmai I; Fendler K; Kollár L; Romhányi M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):278-88. PubMed ID: 2427411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of heparin and pentosan polysulfate on the thermal stability of yeast alcohol dehydrogenase.
    Paulíková H; Molnárová M; Podhradský D
    Biochem Mol Biol Int; 1998 Dec; 46(5):887-94. PubMed ID: 9861442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular weight of heparin versus biologic activity. Some additional considerations.
    Losito R; Losito C
    Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of human elastase from polymorphonuclear leucocytes by gold sodium thiomalate and pentosan polysulfate (SP-54).
    Baici A; Salgam P; Fehr K; Böni A
    Biochem Pharmacol; 1981 Apr; 30(7):703-8. PubMed ID: 6166299
    [No Abstract]   [Full Text] [Related]  

  • 35. Pentosan polysulfate as an inhibitor of calcium oxalate crystal growth.
    Martin X; Werness PG; Bergert JH; Smith LH
    J Urol; 1984 Oct; 132(4):786-8. PubMed ID: 6206244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative turn-over of heparin cofactor II and antithrombin III in baboons. Influence of heparin and pentosan polysulfate administration.
    Sié P; Lansen J; Lacheretz F; Verschuere B; Boneu B
    Thromb Haemost; 1986 Dec; 56(3):302-7. PubMed ID: 2436331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of transplacental passage of pentosan polysulfate during mid trimester of pregnancy.
    Forestier F; Fischer AM; Daffos F; Beguin S; Diner H
    Thromb Haemost; 1986 Dec; 56(3):247-9. PubMed ID: 2436327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pentosane polysulfate: the effect on hemostasis of a continuous 3-day infusion.
    de Prost D; Guérot C; Karsenty F
    Clin Pharmacol Ther; 1985 Aug; 38(2):171-5. PubMed ID: 2410177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption of heparin, LMW heparin and SP54 after subcutaneous injection, assessed by competitive binding assay.
    Dawes J; Prowse CV; Pepper DS
    Thromb Res; 1986 Dec; 44(5):683-93. PubMed ID: 2433788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of pentosan polysulphate (SP54) on the fibrinolytic enzyme system. An experimental animal study.
    Marsh NA; Gaffney PJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):255-61. PubMed ID: 2427408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.